This invention relates to medical drapes, and more specifically to a medical drape system having a tearing feature for easy and clean removal of the drape from a patient.
Medical drapes are widely used during the performance of surgical and other medical procedures as a protective measure. Medical drapes may be used to cover a patient during surgical or other medical procedures. Medical drapes are made sterile and are intended to prevent the possibility of infection being transmitted to the patient. Medical drapes provide protection to the patient by creating a sterile environment surrounding the surgical site and maintaining an effective barrier that minimizes the passage of microorganisms between non-sterile and sterile areas.
It would be advantageous to have medical drapes configured to reduce contamination of sterile fields during medical procedures.
The accompanying figures, where like reference numerals refer to identical or functionally similar elements throughout the separate views and which together with the detailed description below are incorporated in and form part of the specification, serve to further illustrate various embodiments and to explain various principles and advantages all in accordance with the present invention.
Skilled artisans will appreciate that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale. For example, the dimensions of some of the elements in the figures may be exaggerated relative to other elements to help to improve understanding of embodiments of the present invention.
Embodiments of the invention are now described in detail. Referring to the drawings, like numbers indicate like parts throughout the views. As used in the description herein and throughout the claims, the following terms take the meanings explicitly associated herein, unless the context clearly dictates otherwise: the meaning of “a,” “an,” and “the” includes plural reference, the meaning of “in” includes “in” and “on.” Relational terms such as first and second, top and bottom, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, reference designators shown herein in parenthesis indicate components shown in a figure other than the one in discussion. For example, talking about a device (10) while discussing figure A would refer to an element, 10, shown in figure other than figure A.
Healthcare facilities are increasingly concerned about the occurrence of secondary complications occurring during medical and surgical procedures. For example, during a medical procedure on an otherwise healthy patient, such as the insertion of an intravenous catheter, there is the possibility that a secondary infection or other complication can result. As a result, more attention is being turned to establishment and maintenance of sterile fields about patients and procedure sites during medical procedures. For example, some healthcare facilities request medical professionals to check and double check certain conditions, such as whether a proper sterile field has been established or whether a proper sterile field can be maintained. Despite these warnings, it can some times be difficult to remember to check and double check each condition. Further, it can be difficult to maintain sterile fields with some currently existing equipment.
Medical drapes may, for example, be manufactured for use in connection with catheters such as central venous catheters (CVCs). CVCs may be used, for example, for intravenous drug therapy and/or parenteral nutrition. If the catheter or area surrounding the catheter becomes contaminated during or after being inserted into a patient, complications such as catheter site infection, suppurative phlebitis, and/or septicemia may result.
To minimize the risk of infection associated with catheterization, medical drapes often include fenestrations, or apertures, that extend completely through the drape to provide access to an adjacent area of the patient's body (for example, the subclavian area, the brachial area, or the femoral area) over which the respective fenestration lies. Because of the open nature of the fenestrations, a catheter may be inserted through the fenestrations and into the area of the patient's body adjacent to the fenestrations.
It has been generally problematic to remove the medical drape after the medical or surgical procedure is completed. For example, to remove the medical drape, scissors have been used to cut the medical drape from an exterior edge to a fenestration. The use of scissors near the site of the medical or surgical procedure and near the patient is not only awkward and, often, messy, but it is likely to cause injury to the patient or to the user, and can cause damage by cutting catheter or intravenous (IV) lines.
Some current medical drapes include perforations that pass completely through the drape and that form a weakened line, also referred to as a scoreline. To remove the drape, the user pulls the drape apart by hand without the use of any tools, such as scissors. However, one problem associated with this type of scoreline is that the sterile field is reduced because microorganisms can easily pass through the perforations.
Another problem associated with this type of medical drape is that, in general, the scorelines do not allow an easy or clean tear. For example, the tearing motion may require numerous attempts to initiate and complete the tear; the tearing motion may result in a tear-line that is different than the scoreline; and/or the tearing motion may encounter too much material resistance to complete the tear. A scoreline that does not easily tear can lead to frustration of the user, who is likely to continuously pull on the medical drape with a larger and unnecessary force. This, in turn, can lead to contaminants breaching the sterile field and, possibly, to other injuries or damage. For example, constant pulling on the medical drape can cause expensive medical instruments to fall down, or can cause sharp medical instruments to injure other staff, the patient, or the user. Additionally, the pulling involved with the larger and unnecessary force may cause discomfort to the patient who is the recipient of the larger and unnecessary force.
Other current medical drapes include an adhesive tape strip positioned along the length of a drape cut to overlap two adjacent sides of the drape cut. The adhesive tape strip is securely fixed to one side of the drape cut and is removably attached to the other (adjacent) side of the drape cut.
Similar to the medical drapes having scorelines, this type of medical drape fails to provide an easy and clean tear. The removably attached side of the adhesive tape strip often encounters resistance that interferes with easy removal of the medical drape. Furthermore, inadvertent pulling on the medical drape during or before the medical procedure can cause gaps between the removably attached side of the adhesive tape strip and the side of the drape cut to which it is attached. As such, the potential for contaminating the sterile field is greatly increased. Moreover, this type of medical drape involves additional manufacturing steps and costs, such as including a first layer of a permanent adhesive (on the fixed side of the adhesive tape strip) and a second layer of a removable adhesive (on the removable side of the adhesive tape strip). Thus, it would be desirable to have a medical drape that assists in addressing one or more of the above problems. Embodiments of the present invention do just that.
According to one embodiment, a medical drape has a tool-less removal feature and includes a drape material, a drape cut, an adhesive tape strip, and a scoreline. The drape material has a top side, a back side, and at least one exterior edge. The drape cut has a starting point at the exterior edge and extends completely through the thickness of the drape material. The adhesive tape strip is positioned along the length of the drape cut to overlap at least a portion of the drape material on both sides of the drape cut to initially secure the two adjoining cut edges to each other. The scoreline extends along the length of the adhesive tape strip and only partially through the thickness of the adhesive tape strip to permit easy tearing of the adhesive tape strip for separation of the two adjoining cut edges.
According to another embodiment, a method for manufacturing an easily tearable medical drape includes providing a drape material having a top surface and a back surface, the back surface being positioned in contact with a patient when the medical drape is in use, the drape material having at least one exterior edge. The drape material is completely severed to form a drape cut extending from the exterior edge of the drape material to at least an inner area of the drape material, the drape cut being defined by two adjacent cut edges. The two adjacent cut edges are secured to each other by positioning an adhesive strip overlappingly with the drape cut, the adhesive strip extending over a portion of each of the two adjacent cut edges. The adhesive strip is partially severed through its thickness to form a strip scoreline extending along a length of the adhesive strip, the strip scoreline overlapping the drape cut to permit easy tearing of the adhesive strip for separation of the two adjoining cut edges.
According to yet another embodiment, a method for manufacturing a medical drape includes providing a sheet having at least one layer of drape material, and severing the sheet completely through its thickness from an outer edge of the sheet to an inner area of the sheet to form a sheet cut. The sheet cut separates a first sheet area from an adjacent second sheet area. A strip is provided for securing the first sheet area to the second sheet area. The strip is partially severed through its thickness to form a strip scoreline, the strip scoreline separating a first strip area and an adjacent second strip area. A portion of the first strip area is fixed to a portion of the first sheet area and a portion of the second strip area to a portion of the second sheet area such that the strip scoreline is in an overlapping position with respect to the sheet cut.
The above summary of the present invention is not intended to represent each embodiment or every aspect of the present invention. The detailed description and Figures will describe many of the embodiments and aspects of the present invention.
In surgical procedures, many times intravenous (IV) lines or other delivery or drainage lines must remain in the patient after the procedure is complete. Described below in more detail is a medical system for removing a medical or surgical drape after completing a medical or surgical procedure without dislodging any remaining lines. The medical system includes features directed to manually tearing apart the medical drape, by hand, without using any tools (e.g., scissors). An advantage of the medical system is that it eliminates the potential for injury or damage caused by the tools. Another advantage of the medical system is that it consistently provides a clean and smooth tear in the medical drape. A further advantage of the medical system is that the tearing can be easily accomplished with the exertion of little force. Yet another advantage of the medical system is that it eliminates the potential for contamination of a sterile field, by adequately sealing adjoining edges of a drape cut in the medical drape.
Referring to
The medical drape 100 has a front side 104, which faces away from a patient when in use, and a back side 106, which contacts the patient when in use. The medical drape 100 includes a plurality of exterior edges 108a-108c. The main drape material 102 is generally made of a water-repellent or water-impermeable material and/or is coated with such a water-repellent or water impermeable material to prevent the passage of bodily fluids and/or contaminating microorganisms. For example, the main drape material 102 can include various woven, non-woven, hydroentangled materials, and/or combinations thereof. The base fabrics used in the main drape material 102 may include absorbent Airlaid, spunlace, blends of polyester, polypropylene, polyethylene, urethane, and/or combinations thereof. The drape material 102 may be manufactured using various methods, including a spunbond metblown spundbond (SMS) method, a spunbond metblown metblown spundbond method (SMMS), and a spunbond metblown metblown spundbond method (SMMMS).
A fenestration 110 is optionally positioned on and extends completely through the thickness of the main drape material 102. The fenestration 110 allows for a surgical or other medical procedures to be performed therethrough. For example, a catheter tube 112 can be attached directly to the patient through the fenestration 110. In alternative embodiments, additional fenestrations can be positioned on the main drape material 102 and in any suitable location on the main drape material 102. Furthermore, although the fenestration 110 has been illustrated to be generally rectangular in the described embodiment, in alternative embodiments the fenestration(s) can be generally circular, egg-shaped, oval-shaped, pear-shaped, football-shaped, or the like. It is further contemplated that the drape may have any of the properties described herein, regardless of the shape, number, and/or location of the fenestrations.
The fenestration 110 may be covered at least in part with an incise film 114. The composition of the incise film 114 is well known to those skilled in the art of medical drapes. One example of an incise film that may be used is OpSite® Incise film manufactured by Smith & Nephew, Inc. (Memphis, Tenn.). The incise film 114 may be generally transparent so that the health care provider may have clear visibility for locating the correct position for inserting the catheter tube 112 or otherwise accessing the patient site. The incise film 114 may be positioned on the front side 104 or on the back side 106 of the medical drape 100, so long as an exposed adhesive side of the incise film 114 faces toward the patient. The incise film 114 is intended to be removably fixed to the patient, e.g., by attaching the adhesive side to the patient, during the procedure. As such, removal of the medical drape 100 from the patient may be difficult to accomplish without exerting tugging and/or pulling on the medical drape 100 (and, consequently, on the patient), unless removal features are included in the medical drape 100 to facilitate easy tearing.
The incise film 114 includes, optionally, an access port 116 being positioned on and extending completely through the incise film 114. The access port 116 allows the catheter tube 112 to be readily inserted without any cutting, puncturing, or further modification of the medical drape 100 or incise film 114. Although the access port 116 of the illustrated embodiment is circular, it is contemplated that other general shapes including, but not limited to, rectangles, other polygons, circles, and ovals may be used. The access port 116 may have an area ranging from about 3 in2 to about 5 in2 (about 19 cm2 to about 33 cm2). Optionally, additional access ports can be included.
The exposed adhesive side of the incise film 114 is generally covered by at least one release liner 118, which is located on the back side 106 of the main drape material 102. Although the release liner 118 is generally removed when the medical drape 100 is placed over the patient, the release liner 118 of
An adhesive tape strip (or zip strip) 120 is positioned on the main drape material 102, extending from a top exterior edge 108a of the medical drape 100 internally to the access port 116. For example, the adhesive tape strip 120 is glued to the front side 104 of the main drape material 102. Optionally, the adhesive tape strip 120 is glued to the back side 106. In alternative embodiments, the adhesive tape strip 120 extends from any exterior edge 108a-108c to any internal area of the main drape material 102 or to another exterior edge 108a-108c. Any number of adhesive tape strips 120 can be included in the medical drape 100 in any orientation.
According to one embodiment, the adhesive tape strip 120 is a single-coated polyethylene medical tape, such as a medical tape manufactured by 3M (St. Paul, Minn.) as product number 1521. The 3M Medical Tape 1521 is a single-coated tape having a matte finish which includes a transparent polyethylene and is coated with a hypoallergenic, pressure sensitive acrylate adhesive and includes a liner that is silicone treated and is polyethylene coated on one side only along with a bleached Kraft paper release liner. The 3M medical tape has a tape caliper of 6.4 mil (0.16 mm) of polyethylene film tape, a backing of 5.0 mil (0.13 mm) translucent polyethylene film, an acrylate adhesive (designed for medical/surgical use), and a release liner of 83 lb poly-coated Kraft paper, with silicone on one side (6 mils/0.15 mm). The adhesion to steel of the 3M Medical Tape 1521 is 21 ounces/inch width (0.6 kg/25 mm width). Other suitable medical tapes manufactured by 3M and/or other manufacturers may be used in connection with the adhesive tape strip 120.
Referring to
The adhesive tape strip 120 is positioned such that the strip scoreline 120c overlaps a drape cut 122 of the medical drape 100. The drape cut 122, in one embodiment, is formed by completely severing the main drape material 102, the incise film 114, and the release liner 118, from the top exterior edge 108a through the access port 116. In another embodiment, the drape cut 122 is formed by partially severing the main drape material 102, and either partially or completely severing the incise film 114 and the release liner 118. In yet another embodiment, the drape cut 122 can be formed by perforating the main drape material 120, and one of partially severing, completely severing, or perforating the incise film 114 and the release liner 118 as well. Other methods of forming the drape cut 122 will be obvious to those of ordinary skill in the art having the benefit of this disclosure.
In one embodiment, the drape cut 122 is generally defined by two adjoining cut edges, a first cut edge 122a and a second cut edge 122b. The adhesive tape strip 120 secures the adjoining first and second cut edges 122a, 122b of the drape cut 122 to each other by having the first strip side 120a fixed (e.g., glued) to the a first cut edge 122a and having the second strip side 120b fixed to the second cut edge 122b. The bridging area 120d is the only material that holds together the first and second cut edges 122a, 122b.
In addition to securing the drape cut 122, the adhesive tape strip 120 seals the drape cut 122 to eliminate any violation of a sterile field formed on the patient side. Because the strip scoreline 120c extends only through part of the thickness of the adhesive tape strip 120, a protective barrier—the bridging area 120d—is inherently present during the medical procedure.
Referring to
Optionally, one or more additional adhesive tape strips 126, 128, 130, 132 can be positioned on the drape material 102. The adhesive tape strips 126, 128, 130, 132 can be positioned and oriented in any location, can extend from any area to any other area of the drape material 102, and can be of any suitable number.
Referring to
Referring to
The illustrative medical drape 500 of
In one embodiment, the drape material 503 is opaque. In another embodiment, the drape material 503 is transparent. For example, in one embodiment the drape material 503 can be clear 0.05 mm polyethylene sheeting. It should be noted that other clear, flexible materials may be used in place of polyethylene. In another embodiment, the drape material can be manufactured from 45 g spunbond-meltblown-spunbond material. Other materials can be used, as set forth above. The main drape material 503 can generally made of a water-repellent or water-impermeable material and/or is coated with such a water-repellent or water impermeable material to prevent the passage of bodily fluids and/or contaminating microorganisms.
In the illustrative embodiment of
The illustrative embodiment of
In one or more embodiments, a single incise film 508 spans both the first fenestration 504 and the first fenestration 504. The single incise film 508 can be combined with an absorptive element that is disposed about the access ports 506,507 as well. In the illustrative embodiment of
In one or more embodiments, to keep the access ports 507,506 closed until needed, release liners 510,511 can be disposed atop the access ports 506,507. In this illustrative embodiment, the release liners 510,511 are rectangular in shape, although other shapes can be used as well. The release liners 510,511 comprise conventional medical release paper affixed to the patient side of the medical drape 500. One suitable means for affixing the release liners 510,511 to the medical drape 500 is with sections of adhesive tape (not shown). The adhesive tape can be a single-coated polyethylene medical tape, such as a medical tape manufactured by 3M (St. Paul, Minn.) as product number 1521.
In the illustrative embodiment of
The adhesive strips 512,513 of
In one or more embodiments, to show medical personnel where to begin opening the fenestrations 504,505, indicators 518,519, which are shown in a blown-up view in
As shown in
Illustrative dimensions now are provided to further describe one embodiment suitable for use in peripherally inserted central catheter applications. It will be clear to those of ordinary skill in the art having the benefit of this disclosure that these dimensions are examples only, provided to present a clearer image of one embodiment, and can readily be modified based upon application or customer demand.
In one embodiment, the width 509 of the incise film 508 is about fifty-three inches, plus or minus one inch. In one embodiment, the length 520 of the incise film 508 is about twenty-three inches, plus or minus one inch. In one embodiment, the fenestrations 504,505 are about eighteen inches apart from each other. In one embodiment, the access ports 506,507 are disposed a distance 521 of about thirty-five inches from a head end 522 of the medical drape 500. In this illustrative embodiment, the access ports 506,507 are configured as rectangles with a width 523 of about six inches and a height 544 of about five inches. The releasable liners 510,511 have corresponding dimensions of ten inches by eleven inches.
As shown in
Turning now to
The method of
From this point, ends 783,784 of the pre-folded drape assembly 776 are folded towards the center of the pre-folded drape assembly 776 with additional rolling folds 784,785. A book fold 786 can then be applied to form folded drape 778. The steps shown in
Referring to
The illustrative medical drape 5001 has a “dual rectangle” shape when viewed from the front and rear views, with an upper portion 891 being narrower than the lower portion 892. In one embodiment, the upper portion 891 is configured to be wide enough to cover only arm and a portion of the patient's upper torso. The lower portion 892 can be configured to cover the entire lower torso portions of the patient. Generally, these lower torso portions will be at least inferior to the abdominal portion of the patient. Illustrating by example, the upper portion 891 can be configured for positioning over a brachial portion of a patient, a cubital portion of the patient, an antibrachial portion of the patient, or combinations thereof, while the lower portion 8922 can be configured to cover patient portions inferior thereto.
In one or more embodiments, the upper portion 891 and lower portion 892 are manufactured from different materials. In one embodiment well suited for peripherally inserted central catheters, the lower portion 892 is pellucid while the upper portion 891 is opaque. In another embodiment, the lower portion 892 is transparent, while the upper portion 891 is any of non-transparent, opaque, or non-pellucid. For example, in one embodiment the lower portion 892 can be manufactured from clear 0.05 mm polyethylene sheeting. It should be noted that other clear, flexible materials may be used in place of polyethylene. The upper portion 891 can be manufactured from and opaque material, such as 45 g spunbond-meltblown-spunbond material or the other opaque materials mentioned above.
This illustrative medical drape 800 has a length 801 of about one hundred and forty-nine inches, plus or minus one inch, with the lower portion 892 being about eighty-four inches and the upper portion 891 being about sixty-five inches. The lower portion 892 of this illustrative medical drape 800 has a width 802A of about one hundred and six inches, plus or minus one inch. The upper portion 891 of this illustrative medical drape 800 has a width of about thirty-six inches plus or minus one inch.
In the illustrative embodiment of
In one or more embodiments, a single incise film 808 spans both the first fenestration 804 and the first fenestration 804. The single incise film 808 can be combined with an absorptive element that is disposed about the access ports 806,807 as well. In the illustrative embodiment of
In the illustrative embodiment of
Each adhesive strip 812,813 includes a corresponding score line 816,817. The score lines 816,817 permit easy tearing of the adhesive tape strip to open the corresponding drape cut. Usage of the fenestrations 804,805 allows the medical drape 800 to be removed without disturbing, for example, a peripherally inserted central catheter that has been placed through one of the access ports 806,807.
In one or more embodiments, to show medical personnel where to begin opening the fenestrations 804,805, indicators 818,819, which are shown in a blown-up view in
As shown in
Illustrative dimensions now are provided to further describe one embodiment suitable for use in peripherally inserted central catheter applications. It will be clear to those of ordinary skill in the art having the benefit of this disclosure that these dimensions are examples only, provided to present a clearer image of one embodiment, and can readily be modified based upon application or customer demand.
In one embodiment, the width 809 of the incise film 808 is about thirty-six inches, plus or minus one inch. In one embodiment, the length 820 of the incise film 808 is about thirty-two inches, plus or minus one inch. In one embodiment the incise film 808 is disposed about seven inches from the top end 822 of the upper portion 891. In one embodiment, the fenestrations 804,805 are about two and one half inches apart from each other, with each access port 806,807 having a diameter of between one and a half inches and three and a half inches. While not shown in
Turning now to
The method of
From this point, ends 1083,1084 of the pre-folded drape assembly 1076 are folded towards the center of the pre-folded drape assembly 1076 with additional rolling folds 1084,1085. In this embodiment, rolling fold 1085 includes more folds than rolling fold 1084. An asymmetrical book fold 1086 can then be applied to form and asymmetrically book folded drape 1078. The steps shown in
In the foregoing specification, specific embodiments of the present invention have been described. However, one of ordinary skill in the art appreciates that various modifications and changes can be made without departing from the scope of the present invention as set forth in the claims below. Thus, while preferred embodiments of the invention have been illustrated and described, it is clear that the invention is not so limited. Numerous modifications, changes, variations, substitutions, and equivalents will occur to those skilled in the art without departing from the spirit and scope of the present invention as defined by the following claims. Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of present invention. The benefits, advantages, solutions to problems, and any element(s) that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as a critical, required, or essential features or elements of any or all the claim.
This application is a divisional application claiming priority and benefit from U.S. application Ser. No. 13/589,640, filed Aug. 20, 2012, which is incorporated herein by reference for all purposes, which is (1) a continuation-in-part of U.S. application Ser. No. 12/188,931, filed Aug. 8, 2009, which is also incorporated by reference for all purposes, and (2) claims priority under 35 USC § 119(e) to U.S. provisional application Ser. No. 61/538,542, which is also incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
371353 | Perry | Oct 1887 | A |
842224 | Mills | Jan 1907 | A |
850960 | O'Connoor | Apr 1907 | A |
884063 | Baldwin | Apr 1908 | A |
1506332 | Bloom | Aug 1924 | A |
1980435 | Reagan | Nov 1934 | A |
D108151 | Cairns | Jan 1938 | S |
2172162 | Gillette | Aug 1939 | A |
2292347 | Bailey | Aug 1942 | A |
D136385 | Pons | Sep 1943 | S |
D136386 | Pons | Sep 1943 | S |
2374643 | Boettcher | May 1945 | A |
D146506 | Kenny | Mar 1947 | S |
2430941 | Long | Nov 1947 | A |
2431466 | Barri | Nov 1947 | A |
2449584 | Briton | Sep 1948 | A |
2556931 | Miller | Jun 1951 | A |
2653324 | McMahon | Aug 1953 | A |
2668294 | Gilpin | Feb 1954 | A |
2673347 | Weiss | Mar 1954 | A |
2825902 | Marcus | Mar 1958 | A |
2971198 | Tomich | Feb 1961 | A |
D193132 | Rhoads et al. | Jul 1962 | S |
313046 | Mitchell | Apr 1964 | A |
3129432 | Belkin | Apr 1964 | A |
3130462 | Mitchell | Apr 1964 | A |
3144661 | Buser | Aug 1964 | A |
3229305 | Nevitt | Jan 1966 | A |
3276036 | Carter et al. | Oct 1966 | A |
D208527 | Grengg | Sep 1967 | S |
3359569 | Scrivens | Dec 1967 | A |
3397406 | Leach | Aug 1968 | A |
3399406 | Bradley | Sep 1968 | A |
3429433 | Holt | Feb 1969 | A |
3451062 | Bradley | Jun 1969 | A |
3540441 | Collins | Nov 1970 | A |
3625206 | Charnley | Dec 1971 | A |
3696443 | Taylor | Oct 1972 | A |
3707964 | Patience et al. | Jan 1973 | A |
3721997 | Mundt | Mar 1973 | A |
3721999 | Goya et al. | Mar 1973 | A |
3750664 | Collins | Aug 1973 | A |
3803640 | Ericson | Apr 1974 | A |
3824625 | Green | Jul 1974 | A |
D233634 | Snider | Nov 1974 | S |
3858243 | Pierron et al. | Jan 1975 | A |
3868728 | Krzewinski | Mar 1975 | A |
3881474 | Krzewinski | May 1975 | A |
3881476 | Bolker et al. | May 1975 | A |
D236293 | Banks | Aug 1975 | S |
3921221 | Zoephel | Nov 1975 | A |
3935596 | Allen, Jr. et al. | Feb 1976 | A |
3952373 | Noorily | Apr 1976 | A |
3956048 | Nordgren | May 1976 | A |
3968792 | Small | Jul 1976 | A |
3989040 | Lofgren et al. | Nov 1976 | A |
4000521 | Zoephel et al. | Jan 1977 | A |
4017909 | Brandriff | Apr 1977 | A |
4040124 | Zoephel | Aug 1977 | A |
4041942 | Dougan et al. | Aug 1977 | A |
4119093 | Goodman | Oct 1978 | A |
4119095 | Lewis | Oct 1978 | A |
4134398 | Scrivens | Jan 1979 | A |
4153054 | Boone | May 1979 | A |
4171542 | Cox et al. | Oct 1979 | A |
D254276 | Behrmann | Feb 1980 | S |
4214320 | Belkin | Jul 1980 | A |
RE30520 | Pierron | Feb 1981 | E |
4266663 | Geraci | May 1981 | A |
4290148 | Roberts | Aug 1981 | A |
4308864 | Small et al. | Jan 1982 | A |
4315334 | Pearsall | Feb 1982 | A |
4323062 | Canty | Apr 1982 | A |
4334529 | Wirth | May 1982 | A |
D267830 | Arnseth et al. | Feb 1983 | S |
4384573 | Elliott | May 1983 | A |
4397309 | McAllester | Aug 1983 | A |
4408357 | Toth | Oct 1983 | A |
4467477 | DeGennaro | Aug 1984 | A |
4476587 | Itoi | Oct 1984 | A |
4476860 | Collins et al. | Oct 1984 | A |
4479492 | Singer | Oct 1984 | A |
4489720 | Morris et al. | Dec 1984 | A |
4504977 | King et al. | Mar 1985 | A |
4523335 | Scrivens | Jun 1985 | A |
4535481 | Ruth-Larson et al. | Aug 1985 | A |
4553538 | Rafelson | Nov 1985 | A |
4561126 | Truman | Dec 1985 | A |
4569341 | Morris | Feb 1986 | A |
4570268 | Freeman | Feb 1986 | A |
4596245 | Morris | Jun 1986 | A |
4616642 | Martin et al. | Oct 1986 | A |
4622699 | Spriggs | Nov 1986 | A |
4627427 | Arco | Dec 1986 | A |
4631756 | Scrivens | Dec 1986 | A |
4653120 | Leaf | Mar 1987 | A |
4664103 | Martin et al. | May 1987 | A |
4674132 | Stein et al. | Jun 1987 | A |
4686715 | Price | Aug 1987 | A |
4705171 | Eldridge | Nov 1987 | A |
4711236 | Glassman | Dec 1987 | A |
4718124 | Sawicki et al. | Jan 1988 | A |
4736467 | Schwarze et al. | Apr 1988 | A |
4745915 | Enright et al. | May 1988 | A |
4783854 | Bjorklund | Nov 1988 | A |
4829602 | Harreld et al. | May 1989 | A |
4864657 | Lake | Sep 1989 | A |
4869271 | Idris | Sep 1989 | A |
D305376 | Russell | Jan 1990 | S |
D305575 | Gordon et al. | Jan 1990 | S |
4905710 | Jones | Mar 1990 | A |
4920578 | Janzen et al. | May 1990 | A |
4942987 | Stackhouse | Jul 1990 | A |
4951317 | Gray et al. | Aug 1990 | A |
4951318 | Harreld et al. | Aug 1990 | A |
4964173 | Gordon | Oct 1990 | A |
4969215 | Burkett | Nov 1990 | A |
5010592 | Skiles, Jr. | Apr 1991 | A |
5027438 | Schwarze et al. | Jul 1991 | A |
5029344 | Shannon et al. | Jul 1991 | A |
5033115 | Bowling et al. | Jul 1991 | A |
D319113 | Adams | Aug 1991 | S |
5042507 | Dowdy | Aug 1991 | A |
5061246 | Anapliotis | Oct 1991 | A |
5063919 | Silverberg | Nov 1991 | A |
5074316 | Dowdy | Dec 1991 | A |
5088116 | Gould | Feb 1992 | A |
5097534 | Viemeister et al. | Mar 1992 | A |
5109873 | Marshall | May 1992 | A |
5135188 | Anderson et al. | Aug 1992 | A |
5136758 | Wilcox et al. | Aug 1992 | A |
5140996 | Sommers | Aug 1992 | A |
5143091 | Patnode | Sep 1992 | A |
5184351 | Benstock | Feb 1993 | A |
5253642 | Stackhouse et al. | Oct 1993 | A |
5271100 | Holt | Dec 1993 | A |
D348974 | Whitwill | Jul 1994 | S |
5345946 | Butterworth et al. | Sep 1994 | A |
D351712 | Jackson | Oct 1994 | S |
5362306 | McCarver et al. | Nov 1994 | A |
5372589 | Davis | Dec 1994 | A |
5377387 | Freed | Jan 1995 | A |
D356204 | Derrickson | Mar 1995 | S |
5410758 | Dupont et al. | May 1995 | A |
5414867 | Bowling et al. | May 1995 | A |
5417225 | Rubenstein et al. | May 1995 | A |
5444871 | Lopez | Aug 1995 | A |
5444872 | Johnson | Aug 1995 | A |
5444873 | Levin | Aug 1995 | A |
D362331 | Berger, II | Sep 1995 | S |
5454119 | Thomm | Oct 1995 | A |
5533209 | Davis | Jul 1996 | A |
D374113 | Console | Oct 1996 | S |
5561861 | Lopez et al. | Oct 1996 | A |
5575006 | Wolfe | Nov 1996 | A |
5605534 | Hutchison | Feb 1997 | A |
5611356 | Rothrum | Mar 1997 | A |
5674189 | McDowell et al. | Oct 1997 | A |
5694643 | Fujiwara | Dec 1997 | A |
5707703 | Rothrum et al. | Jan 1998 | A |
5765566 | Rothrum | Jun 1998 | A |
5768707 | Lederer | Jun 1998 | A |
5778889 | Jascomb | Jul 1998 | A |
5778891 | McMahan | Jul 1998 | A |
5784718 | Finnegan | Jul 1998 | A |
5806094 | Kasun et al. | Sep 1998 | A |
5813051 | Counter | Sep 1998 | A |
5813052 | Taylor | Sep 1998 | A |
5816253 | Sosebee | Oct 1998 | A |
5862525 | Tankersley et al. | Jan 1999 | A |
5867825 | Scheerer | Feb 1999 | A |
5916202 | Haswell | Jun 1999 | A |
5973450 | Nishizawa et al. | Oct 1999 | A |
5975082 | Dowdy | Nov 1999 | A |
5985395 | Comstock et al. | Nov 1999 | A |
D419748 | Sartori | Feb 2000 | S |
6049907 | Palomo | Apr 2000 | A |
6062444 | Tankersley et al. | May 2000 | A |
6105579 | Levitt | Aug 2000 | A |
6115840 | Hastings | Sep 2000 | A |
D431344 | Briceno | Oct 2000 | S |
6138278 | Taylor | Oct 2000 | A |
6196033 | Dowdle | Mar 2001 | B1 |
6216270 | Moquin et al. | Apr 2001 | B1 |
6235659 | McAmish et al. | May 2001 | B1 |
6244268 | Annett | Jun 2001 | B1 |
6272685 | Kumar | Aug 2001 | B1 |
6285611 | Kang | Sep 2001 | B1 |
6345622 | Chandler | Feb 2002 | B1 |
6405730 | Levitt et al. | Feb 2002 | B2 |
6378136 | Matsushita | Aug 2002 | B2 |
D463093 | Murray | Sep 2002 | S |
6449772 | Donner et al. | Sep 2002 | B1 |
D469945 | Mayer | Feb 2003 | S |
6536636 | McDonniel | Mar 2003 | B1 |
6564386 | Fujikawa et al. | May 2003 | B2 |
6601239 | Drake | Aug 2003 | B2 |
6665880 | Poppe | Dec 2003 | B2 |
6694981 | Gingles et al. | Feb 2004 | B2 |
6742522 | Baker et al. | Jun 2004 | B1 |
6820622 | Teves et al. | Nov 2004 | B1 |
6843252 | Harrison et al. | Jan 2005 | B2 |
6990686 | Palmer | Jan 2006 | B2 |
7114500 | Bonutti | Oct 2006 | B2 |
D533982 | Graneto, III | Dec 2006 | S |
7181773 | Piraka | Feb 2007 | B1 |
7237271 | McLandrich | Jul 2007 | B1 |
7290547 | Joseph et al. | Nov 2007 | B2 |
7293654 | Wilson et al. | Nov 2007 | B1 |
7305991 | Santilli et al. | Dec 2007 | B2 |
D563627 | Warren | Mar 2008 | S |
D565279 | Farrell | Apr 2008 | S |
7370369 | Cheung | May 2008 | B2 |
7412728 | Alesina et al. | Aug 2008 | B2 |
D575936 | Fenderson et al. | Sep 2008 | S |
D579178 | Snyder et al. | Oct 2008 | S |
7454798 | Feodoroff | Nov 2008 | B2 |
D584483 | Glynn | Jan 2009 | S |
7549179 | Saied | Jun 2009 | B1 |
D598638 | Graneto, III | Aug 2009 | S |
7594279 | Roy | Sep 2009 | B2 |
D608980 | Brady | Feb 2010 | S |
7654266 | Corbitt, Jr. | Feb 2010 | B2 |
D612126 | Milgrom | Mar 2010 | S |
7673754 | Wilson, Jr. et al. | Mar 2010 | B2 |
D618884 | Zhu | Jul 2010 | S |
D622479 | Herzog | Aug 2010 | S |
D622934 | Graneto, III | Sep 2010 | S |
7819911 | Anderson et al. | Oct 2010 | B2 |
7841020 | Mayfield et al. | Nov 2010 | B2 |
7926120 | Birmingham | Apr 2011 | B2 |
7971274 | Graneto, III | Jul 2011 | B2 |
8006836 | Trombetta | Aug 2011 | B2 |
D646463 | Petrovskis et al. | Oct 2011 | S |
D647688 | Hilgart | Nov 2011 | S |
8056146 | Porowski | Nov 2011 | B2 |
8069495 | Kemper | Dec 2011 | B2 |
D653019 | Bond | Jan 2012 | S |
D655479 | Umbach et al. | Mar 2012 | S |
D657530 | Farris et al. | Apr 2012 | S |
8162137 | Vellutato, Jr. et al. | Apr 2012 | B2 |
8286263 | Sampson-Howlett | Oct 2012 | B2 |
8332965 | Ryer | Dec 2012 | B1 |
8343182 | Kirkham | Jan 2013 | B2 |
8375466 | Tasezen et al. | Feb 2013 | B2 |
D680709 | Blood | Apr 2013 | S |
8464374 | Thayer | Jun 2013 | B1 |
D687209 | Levine | Aug 2013 | S |
D690078 | Anderson | Sep 2013 | S |
D698529 | Vanneste | Feb 2014 | S |
8677513 | Mathis et al. | Mar 2014 | B2 |
D719721 | Bonfiglio | Dec 2014 | S |
D721870 | Levine | Feb 2015 | S |
D736493 | Pasko | Aug 2015 | S |
D737546 | Sewall | Sep 2015 | S |
D741044 | Pasko | Oct 2015 | S |
9330799 | Phillips | May 2016 | B1 |
D779155 | Pasko et al. | Feb 2017 | S |
D779156 | Pasko | Feb 2017 | S |
D785284 | Pasko | May 2017 | S |
D787780 | Pasko | May 2017 | S |
20010032346 | Matsushita et al. | Oct 2001 | A1 |
20020095709 | Fujikawa et al. | Jul 2002 | A1 |
20030060831 | Bonutti | Mar 2003 | A1 |
20030121522 | Gingles et al. | Jul 2003 | A1 |
20030131401 | Dilworth | Jul 2003 | A1 |
20030188753 | Jascomb | Oct 2003 | A1 |
20040019951 | Cioffi | Feb 2004 | A1 |
20040103904 | Auerbach et al. | Jun 2004 | A1 |
20040123366 | Schorr et al. | Jul 2004 | A1 |
20040172734 | Hartbrodt | Sep 2004 | A1 |
20050044608 | Ambrose et al. | Mar 2005 | A1 |
20050132465 | Kathumbi-Jackson et al. | Jun 2005 | A1 |
20050145254 | Aboul-Hosn et al. | Jul 2005 | A1 |
20050223468 | Hatton | Oct 2005 | A1 |
20050279366 | Adragna | Dec 2005 | A1 |
20060000002 | Bergkvist | Jan 2006 | A1 |
20060064797 | Pyeatt Rowe | Mar 2006 | A1 |
20060081261 | Corbitt, Jr. | Apr 2006 | A1 |
20060107434 | Rowe | May 2006 | A1 |
20060117452 | Ambrose | Jun 2006 | A1 |
20060117456 | Griesbach | Jun 2006 | A1 |
20060177655 | Mizohata et al. | Aug 2006 | A1 |
20060191541 | Aboul-Hosn et al. | Aug 2006 | A1 |
20060236440 | Zahler | Oct 2006 | A1 |
20060277655 | Kerr | Dec 2006 | A1 |
20060277668 | Plut et al. | Dec 2006 | A1 |
20060286334 | Harpole | Dec 2006 | A1 |
20070061940 | Cazares | Mar 2007 | A1 |
20070102005 | Bonutti | May 2007 | A1 |
20070113859 | Allen | May 2007 | A1 |
20070130668 | Berman et al. | Jun 2007 | A1 |
20080006279 | Bodenham et al. | Jan 2008 | A1 |
20080023013 | Tuke et al. | Jan 2008 | A1 |
20080047567 | Bonutti | Feb 2008 | A1 |
20080115253 | Gorman | May 2008 | A1 |
20080155728 | Hafer et al. | Jul 2008 | A1 |
20080178365 | Furgerson et al. | Jul 2008 | A1 |
20090165186 | Mijares et al. | Jul 2009 | A1 |
20090183529 | Modiano | Jul 2009 | A1 |
20090277460 | Carrez et al. | Nov 2009 | A1 |
20090320177 | Lin et al. | Dec 2009 | A1 |
20100031966 | Allen | Feb 2010 | A1 |
20100064408 | Kemper | Mar 2010 | A1 |
20100138975 | Jordan et al. | Jun 2010 | A1 |
20100186754 | Carrez | Jul 2010 | A1 |
20100212063 | Baucom et al. | Aug 2010 | A1 |
20100299805 | Graneto, III | Dec 2010 | A1 |
20100300459 | Lair | Dec 2010 | A1 |
20100313323 | Tennelle | Dec 2010 | A1 |
20110023210 | Porowski | Feb 2011 | A1 |
20110024485 | Porowski | Feb 2011 | A1 |
20110154554 | Furlong | Jun 2011 | A1 |
20110167534 | Wong et al. | Jul 2011 | A1 |
20110231981 | Appel et al. | Sep 2011 | A1 |
20110315150 | Bream, Jr. | Dec 2011 | A1 |
20120047623 | van Oudenallen et al. | Mar 2012 | A1 |
20120054940 | Halseth | Mar 2012 | A1 |
20120060257 | Herzog | Mar 2012 | A1 |
20120124722 | Yadav et al. | May 2012 | A1 |
20120167896 | Hartmann et al. | Jul 2012 | A1 |
20120305541 | Giles | Dec 2012 | A1 |
20120312308 | Allen | Dec 2012 | A1 |
20130091615 | Pasko et al. | Apr 2013 | A1 |
20130091616 | Muche et al. | Apr 2013 | A1 |
20130191960 | Pasko | Aug 2013 | A1 |
20130198930 | Levine | Aug 2013 | A1 |
20130239290 | Rossi | Sep 2013 | A1 |
20130276204 | Pasko et al. | Oct 2013 | A1 |
20130318682 | Graneto, III | Dec 2013 | A1 |
20140007316 | Tommarello et al. | Jan 2014 | A1 |
20140082816 | Christopher | Mar 2014 | A1 |
20140173814 | Yadav et al. | Jun 2014 | A1 |
20140182043 | Moore | Jul 2014 | A1 |
20140189931 | Fredrickson | Jul 2014 | A1 |
20140215681 | Goodman | Aug 2014 | A1 |
20150089712 | Gamble | Apr 2015 | A1 |
20150096099 | Vanneste | Apr 2015 | A1 |
20150113698 | Gregerson-Brown | Apr 2015 | A1 |
20150135397 | Levine | May 2015 | A1 |
20150135398 | Czajka et al. | May 2015 | A1 |
20150208741 | Pasko | Jul 2015 | A1 |
20150213215 | Kobayashi et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
2343482 | Oct 2001 | CA |
2799116 | Aug 2013 | CA |
302083878 | Sep 2012 | CN |
8904426 | May 1989 | DE |
202006005966 | Oct 2006 | DE |
102009024999 | Dec 2010 | DE |
102011016497 | Oct 2012 | DE |
001320857 | Mar 2012 | EM |
143204 | Jun 1985 | EP |
0166124 | Jan 1986 | EP |
0335041 | Oct 1989 | EP |
335041 | Oct 1989 | EP |
1362520 | Nov 2003 | EP |
1407324-0001 | May 2014 | EP |
1407324-0002 | May 2014 | EP |
1407324-0003 | May 2014 | EP |
1407324-0004 | May 2014 | EP |
2709643 | Mar 1995 | FR |
2896146 | Jul 2007 | FR |
2001-510704 | Aug 2001 | JP |
2011167417 | Sep 2011 | JP |
101116311 | Mar 2012 | KR |
8602258 | Apr 1986 | WO |
9904721 | Feb 1999 | WO |
2001030258 | May 2001 | WO |
2007083032 | Jul 2007 | WO |
2008146138 | Dec 2008 | WO |
2011038792 | Apr 2011 | WO |
201459401 | Oct 2014 | WO |
Entry |
---|
Opera, Karen , “Office Action”, Canadian Application No. 2,847,495; dated Oct. 24, 2018. |
3M Product Clinical Data Summary for No. 1521, 3M Plastic Medical Tape, Jan. 1996 (2 pages). |
3M Technical Information Sheet, Product No. 1521, Feb. 2007 (2 pages). |
Blue Medical Gown; Manufactured by Medline Industries, Inc.; Unknown availability date but believed to be prior to 1999. |
Country Living down under. <URL: http://countrylivingdownunder.yuku.com/topic/6395/How-to-attach-elastic-to-gather-andto-shit#.WQCbi_krJaQ.> Jun. 2, 2014. Gathering with elastic. |
Definition of Progressive. Merriam-Webster. Merriam-Webster, n.d. Web. May 17, 2016. |
Description and Photographs of 75-1040 Fenestrated Snap Drape (as of Oct. 6, 2008) (1 page). |
Description and Photographs of a Perforated Drape With Tear Line (as of Oct. 6, 2008) (1 page). |
Description and Photographs of D-09875-001 Snap Drape (as of Oct. 6, 2008) (1 page). |
Description and Photographs of Perforated Drapes (as of Oct. 6, 2008) (2 pages). |
Disposable Medical Gown; Elastic Cuffs; Salamint, posted at salaaming.com, posting date n/a, copyright 2015 salamin.com, online, site visit Mar. 11, 2016; Available from https://www.salamint.com/productdetail.aspx?id=358. |
Disposable Medical Gown; Thumb Loop Plastic Disposable Medical Surgical Gown, posting date n/a, copyright 1999-2016 alibaba.com; site visited Mar. 11, 2016, available from http://www.alibaba.com/product-detail/CPE-Gown-Thumb-loop-White-color_60043196775.html. |
European Search Report for European Applicafion No. 09167307.9 dated Oct. 11, 2010 (5 pages). |
Fashion Flats, <URLL http:fashion-flats.com/images/1_details_set_in_sleeves.jpr> Visited by Examiner May 21, 2015; Types of set-in sleeves. |
Go Japan Go. <URL: http://www.gojapangp.com/fashion/hadajuban_kimono.html>. Visited Feb. 4, 2016. Hadajuban. |
Jendela Sastra. <URL: http://www.jendelasatra.com/karya/puisi/hadajuban-dalam-kimono>. Poem with picture published Jan. 10, 2014. Hadajuban (first layer of kimono). |
Lyst. <URL: https://ww.lyst.com/clothing/chritophe-lemaire-yak-hair-wool-thumbhole-sweater-moss-stone/.> Visited Apr. 26, 2017 by Examiner of U.S. Appl. No. 29/545,806; Chritophe Lemaire Thumbhole Sweater. |
Medical Single Coated Film Tapes Selection Guide—Polyolefin & Vinyl, Nov. 1996 (3 pages). |
Rakuten. <URL: http://global.rakuten.com/en/store/753ya/item/100131328/[2/4/2016%201:51:48%20PM]>. Visited Feb. 4, 2016. Hada-Juban. |
Sakura-San. <URL: http://www.sakura-san.de/Juban.htm> Saved Jul. 12, 2013. Juban Furisode and Hada-Juban layers for kimono. |
The visual dictionary. <RURL: http://www.infovisual.info/06/049_en.html> Jun. 1, 2013. types of cuffs. |
Vintage Patterns Wikia. <URL: https//vintagepatterns.wikia.com/wiki/Butterikc_5374.> visited Dec. 9, 2015. Butterick 5374—Vintage Sewing Blouse Pattern. |
“Appeal Decision”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated May 31, 2016. |
“BurdaStyle Women's Size Chart”, http://www.burdastyle.com/downloads/SizeChart_Regular_inches.pdf; Publication Date Unknown. |
“Extended European Search Report”, EP Application No. 12790027.2; PCT/US2012/032122; dated Jan. 5, 2015. |
“Final OA”, U.S. Appl. No. 14/086,798, filed Nov. 21, 2013; dated Feb. 1, 2016. |
“First Office Action”, CN Application No. 201280046346.4; filed Sep. 11, 2012; dated Aug. 26, 2015. |
“Medline Catalog”, 2-Ply Sterile Cotton Stockinette by Alba-Waldensian; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Cotton Stockinette by Alba-Waldensian; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Full BodyDrapes by Halyard Health; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, K-C100 Mayo Stand Covers by Halyard Health; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Midline Cath Picc Kits by Medikmark; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, PICC Full Body Coverage Pack by Halyard Health; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Single Ply Standard Stockinettes by DeRoyal; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Single-Ply Sterile Stockinettes by Kerma Medical; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Sterile Bias Cute Cuttron Stockinette by Alba-Waldensian; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Stockinette by Derma Sciences; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Strl Stockinette Cttn 1-Ply by Alba-Waldensian; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, TG Stockinettes by Lohmann and Rauscher; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Tube, Luki 864304; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Notice of Allowance”, Japanese App No. 2015-531859; dated Nov. 24, 2016. |
“Office Action”, Australian Patent Application 2012304800; dated Nov. 22, 2016. |
“Office Action”, Canadian Office Action for Canadian Patent No. 2,674,951 dated May 4, 2011 (3 pages). |
“Office ACtion”, Chinese App No. 201280046346.4; dated Apr. 21, 2016. |
“Office Action”, Chinese App No. 201280046346.4; dated Oct. 21, 2016. |
“Office Action”, JP Application No. 2014-531859; dated May 2, 2016. |
“Publication”, Fashion Flats by Garment Element; by Art Design Projects Inc.; www.fashioncroquis.com; visited May 21, 2015; types of raglan sleeves. |
Byun, Sung C. , “PCT Search Report”, PCT No. PCT/US2012/052079; Filed Aug. 23, 2012; dated Dec. 26, 2012. |
Chang, Bong Ho , “PCT Search Report and Written Opinion”, PCT/US2012/054659; Filed Sep. 11, 2012; dated Feb. 26, 2013. |
Cline, Sally , “Restriction Req”, U.S. Appl. No. 13/804,565, filed Mar. 14, 2013; dated Aug. 13, 2015. |
Fitts, Carissa , “Final OA”, U.S. Appl. No. 29/404,295, filed Oct. 18, 2011; dated Feb. 19, 2015. |
Fitts, Carissa , “Final OA”, U.S. Appl. No. 29/404,296, filed Oct. 18, 2011; dated Jul. 2, 2015. |
Fitts, Carissa , “Final OA”, U.S. Appl. No. 29/467,622, filed Sep. 20, 2013; dated Jul. 12, 2016. |
Fitts, Carissa , “Final OA”, U.S. Appl. No. 29/536,646, filed Aug. 18, 2015; dated Oct. 4, 2017. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/404,295, filed Oct. 18, 2011; dated Jul. 1, 2014. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/404,296, filed Oct. 18, 2011; dated Apr. 22, 2016. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/404,296, filed Oct. 8, 2011; dated Oct. 9, 2014. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/467,622, filed Sep. 20, 2013; dated Dec. 30, 2015. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/467,622, filed Sep. 20, 2013; dated May 2, 2017. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/467,623, filed Sep. 20, 2013; dated Jan. 13, 2016. |
Fitts, Carissa , “NonFinal OA”, U.S. Appl. No. 29/536,646, filed Aug. 18, 2015; dated Jun. 27, 2017. |
Fitts, Carissa , “Notice of Allowance”, U.S. Appl. No. 29/404,296, filed Oct. 18, 2011; dated Oct. 7, 2016. |
Fitts, Carissa , “Notice of Allowance”, U.S. Appl. No. 29/467,622, filed Sep. 20, 2013; dated Sep. 26, 2017. |
Fitts, Carissa C , “Notice of Allowance”, U.S. Appl. No. 29/467,623, filed Sep. 20, 2013; dated Jan. 13, 2017. |
Gimenez Burgos, R , “Extended European Search Report”, App No. 12834067.6-1659/2747697; Reference No. SJG/P131778EP00. |
Gimenez Burgos, R , “Extended European Search Report”, EP 12829356.0-1659/2747696; PCT/US2012052079; Reference No. SJG/P131402EP00; dated Feb. 16, 2015. |
Haden, Sally , “Appeal Decision”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; mailed Jun. 6, 2017. |
Haden, Sally , “Final OA”, U.S. Appl. No. 13/925,598, filed Jun. 24, 2013; dated Sep. 6, 2016. |
Haden, Sally , “NonFinal OA”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated Aug. 11, 2016. |
Haden, Sally , “NonFinal OA”, U.S. Appl. No. 13/925,532, filed Jun. 24, 2013; dated Jan. 8, 2016. |
Haden, Sally , “NonFinal OA”, U.S. Appl. No. 13/925,598, filed Jun. 24, 2013; dated Dec. 15, 2015. |
Haden, Sally , “NonFinal Office Action”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; dated May 21, 2018. |
Haden, Sally , “Notice of Allowance”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; dated Sep. 12, 2017. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated Jul. 17, 2013. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 13/804,565, filed Mar. 14, 2013; dated May 19, 2016. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 13/804,565, filed Mar. 14, 2013; dated May 8, 2017. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2007; dated Dec. 3, 2013. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; dated Dec. 3, 2013. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 14/942,755, filed Nov. 16, 2015; dated Mar. 27, 2018. |
Haden, Sally C. , “Final Office Action”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated Jan. 13, 2017. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated Apr. 8, 2013. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 13/804,565, filed Mar. 14, 2013; dated Oct. 29, 2015. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; dated Aug. 13, 2014. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; dated Aug. 14, 2013. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 14/679,628, filed Apr. 6, 2015; dated Sep. 5, 2017. |
Haden, Sally Cline , “Final OA”, U.S. Appl. No. 13/925,532, filed Jun. 24, 2013; dated Sep. 26, 2016. |
Haden, Sally Cline , “NonFinal OA”, U.S. Appl. No. 13/804,565, filed Mar. 14, 2013; dated Jan. 19, 2017. |
Haden, Sally Cline , “NonFinal OA”, U.S. Appl. No. 13/925,532, filed Jun. 24, 2013; dated Aug. 9, 2017. |
Haden, Sally Cline , “NonFinal OA”, U.S. Appl. No. 13/925,532, filed Jun. 24, 2013; dated May 23, 2016. |
Haden, Sally Cline , “NonFinal OA”, U.S. Appl. No. 13/925,598, filed Jun. 24, 2013; dated May 24, 2016. |
Haden, Sally Cline , “NonFinal OA”, U.S. Appl. No. 14/942,755, filed Nov. 16, 2015; dated Sep. 8, 2017. |
Haines, Kimberly , “Notice of Allowance”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated May 2, 2017. |
Harris, Raymond E. , “NonFinal OA”, U.S. Appl. No. 12/537,961, filed Aug. 17, 2009; dated Jul. 17, 2012. |
Harris, Raymond E. , “Final OA”, U.S. Appl. No. 12/537,961, filed Aug. 7, 2009; dated Nov. 21, 2012. |
Harris, Raymond E. , “Final Office Action”, U.S. Appl. No. 12/537,961, filed Aug. 7, 2009; dated Apr. 11, 2012. |
Harris, Raymond E. , “Non-Final Office Action”, U.S. Appl. No. 12/537,961, filed Aug. 7, 2009; dated Nov. 9 2011. |
Hicks, Victoria , “Final OA”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated Nov. 22, 2013. |
Hicks, Victoria , “Final OA”, U.S. Appl. No. 13/229,743, filed Sep. 11, 2011; dated Aug. 7, 2014. |
Hicks, Victoria , “Final OA”, U.S. Appl. No. 13/589,640, filed Aug. 20, 2012; dated Jan. 2, 2015. |
Hicks, Victoria , “NonFinal OA”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated May 16, 2013. |
Hicks, Victoria , “NonFinal OA”, U.S. Appl. No. 13/229,743, filed Sep. 11, 2011; dated Feb. 10, 2014. |
Hicks, Victoria , “NonFinal OA”, U.S. Appl. No. 13/589,640, filed Aug. 20, 2012; dated Jun. 13, 2014. |
Hicks, Victoria , “Notice of Allowance”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated Aug. 15, 2017. |
Hicks, Victoria , “Notice of Allowance”, U.S. Appl. No. 13/229,743, filed Sep. 11, 2011; dated Jan. 2, 2018. |
Hicks, Victoria , “Notice of Allowance”, U.S. Appl. No. 13/589,640, filed Aug. 20, 2012; dated Dec. 19, 2017. |
Lee, Cheol Soo , “International Search Report”, PCT/US2012/032122; Filed Apr. 4, 2012; dated Nov. 1, 2012. |
Lee, Jong Kyung , “PCT Search Report and Written Opinion”, PCT/US2014/023432; Filed Mar. 11, 2014; dated Jul. 10, 2014. |
McVey, Lauren , “Ex Parte Quayle”, U.S. Appl. No. 29/467,603, filed Sep. 20, 2013; Mailed Jul. 26, 2017. |
McVey, Lauren , “Final OA”, U.S. Appl. No. 29/459,047, filed Jun. 25, 2013; dated Sep. 24, 2015. |
McVey, Lauren , “Final OA”, U.S. Appl. No. 29/467,616, filed Sep. 20, 2013; dated Nov. 3, 2015. |
McVey, Lauren , “Final OA”, U.S. Appl. No. 29/467,619, filed Sep. 20, 2013; dated Oct. 20, 2015. |
McVey, Lauren , “Final OA”, U.S. Appl. No. 29/467,621, filed Sep. 20, 2013; dated Apr. 11, 2016. |
McVey, Lauren , “Final OA”, U.S. Appl. No. 29/467,603, filed Sep. 20, 2013; dated Feb. 10, 2016. |
McVey, Lauren , “Final Office Action”, U.S. Appl. No. 29/467,603, filed Sep. 20, 2013; dated Feb. 8, 2017. |
McVey, Lauren , “Final Office Action”, U.S. Appl. No. 29/545,802, filed Nov. 16, 2015; dated May 17, 2018. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/459,047, filed Jun. 25, 2013; dated Apr. 23, 2015. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/467,603, filed Sep. 30, 2015; dated Jun. 30, 2015. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/467,612, filed Sep. 20, 2013; dated Jun. 5, 2015. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/467,616, filed Sep. 20, 2013; dated Jun. 17, 2015. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/467,621, filed Sep. 20, 2013; dated Aug. 26, 2015. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/467,625, filed Sep. 20, 2013; dated Jul. 29, 2015. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/545,802, filed Nov. 16, 2015; dated Jun. 1, 2017. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/545,805, filed Nov. 16, 2015; dated Jun. 2, 2017. |
McVey, Lauren , “NonFinal OA”, U.S. Appl. No. 29/545,806, filed Nov. 16, 2015; dated Jun. 1, 2017. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/459,047, filed Jun. 25, 2013; dated Aug. 10, 2016. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/459,047, filed Jun. 25, 2013; dated Oct. 19, 2016. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/459,060, filed Jun. 25, 2013; dated Apr. 23, 2015. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/467,616, filed Sep. 20, 2013; dated Aug. 10, 2016. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/467,620, filed Sep. 20, 2013; dated Jun. 23, 2015. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/467,621, filed Sep. 20, 2013; dated Oct. 20, 2016. |
McVey, Lauren , “Notice of Allowance”, U.S. Appl. No. 29/467,623, filed Sep. 20, 2013; dated Aug. 30, 2016. |
McVey, Lauren D. , “NonFinal OA”, U.S. Appl. No. 29/467,619, filed Sep. 20, 2013; dated May 20, 2015. |
Oprea, Karen , “NonFinal OA”, Canadian Application No. 2,847,495; dated Jan. 22, 2018. |
Oprea, Karen , “NonFinal OA”, Canadian Application No. 2,848,634; dated Mar. 15, 2018; Reference No. 15468-P45942CA00. |
Pandika, Kylie , “Examination Report”, Australian Patent Application No. 2012312845; Filed Sep. 23, 2011; dated Nov. 1, 2016. |
Reed, Richard , “First Examination Report”, Australian Application No. 2012259325; Exam Request Date Mar. 5, 2015; Reference No. 35210639/GCP; dated Nov. 30, 2015. |
Sato, Tomoya , “NonFinal Office Action”, Japanese Patent Application No. 2017-121386; dated Dec. 27, 2017. |
Vanatta, Amy , “Non-Final Office Action”, U.S. Appl. No. 12/720,360, filed Mar. 9, 2010; dated Oct. 11, 2011. |
Vanatta, Amy B. , “Notice of Allowance”, U.S. Appl. No. 12/720,360, filed Mar. 9, 2012; dated Feb. 9, 2012. |
Walshon, Rashida , “Final OA”, U.S. Appl. No. 29/506,290, filed Oct. 14, 2014; dated Jul. 28, 2016. |
Walshon, Rashida , “NonFinal OA”, U.S. Appl. No. 29/506,290, filed Oct. 14, 2014; dated Jan. 20, 2016. |
Walshon, Rashida , “NonFinal OA”, U.S. Appl. No. 29/591,354, filed Jan. 19, 2017; dated Oct. 4, 2017. |
Walshon, Rashida , “Non-Final OA”, U.S. Appl. No. 29/591,354, filed Jan. 19, 2017; dated Apr. 17, 2018. |
Wright, Jennifer , “NonFinal OA”, U.S. Appl. No. 29/506,294, filed Oct. 14, 2014; dated Mar. 28, 2016. |
Wright, Jennifer , “NonFinal OA”, U.S. Appl. No. 29/506,294, filed Oct. 14, 2014; dated Sep. 23, 2016. |
Wu, Jocelyn Mary , “NonFinal OA”, U.S. Appl. No. 14/086,798, filed Nov. 21, 2013; dated Sep. 24, 2015. |
Ambrosch, Jeannette , “Notice of Allowance”, EP Application No. 12834067.6; dated Oct. 11, 2019. |
Bravo, Jocelyn , “NonFinal OA”, U.S. Appl. No. 14/086,798, filed Nov. 21, 2013; dated May 20, 2019. |
Bravo, Jocelyn M. , “NonFinal OA”, U.S. Appl. No. 14/086,798, filed Nov. 21, 2013; dated Dec. 11, 2019. |
Emirdag, Eda , “Exam Report”, EP Application No. 12829356.0-1113; dated Sep. 12, 2019. |
Emirdag, Eda , “Office Action”, European Application No. 12829356.0; dated Apr. 8, 2020. |
Number | Date | Country | |
---|---|---|---|
20180296295 A1 | Oct 2018 | US |
Number | Date | Country | |
---|---|---|---|
61538642 | Sep 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13589640 | Aug 2012 | US |
Child | 16016326 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12188931 | Aug 2008 | US |
Child | 13589640 | US |